-
3 weeks ago | 
auntminnieeurope.com | Will Morton |Philip Ward |Edna Astbury-Ward
The European Association of Nuclear Medicine (EANM) has added 50 spots in its initiative to support the younger generation of nuclear medicine professionals, the Next-Gen Program. Accepted applicants (under the age of 39) will receive free registration, free accommodation, and specific opportunities to network at the association’s 2025 annual meeting to be held from 4 to 8 October in Barcelona, Spain. Last year, EANM received 600 applications for 100 spots, and is offering 150 spots this year.
-
3 weeks ago | 
auntminnieeurope.com | Philip Ward |Edna Astbury-Ward |Will Morton |Erik L. Ridley
German radiotheranostics company Navigo Proteins has entered a strategic research collaboration with SCK CEN, a Belgian nuclear research center. The partnership will focus on the preclinical development of next-generation radiotheranostics cancer treatments using the radioisotope terbium-161 (Tb-161). Navigo has developed carrier molecules, while SCK CEN provides Tb-161, infrastructure, and expertise in preclinical testing.
-
3 weeks ago | 
auntminnieeurope.com | Philip Ward |Edna Astbury-Ward |Will Morton |Erik L. Ridley
German radiotheranostics company Navigo Proteins has entered a strategic research collaboration with SCK CEN, a Belgian nuclear research center. The partnership will focus on the preclinical development of next-generation radiotheranostics cancer treatments using the radioisotope terbium-161 (Tb-161). Navigo has developed carrier molecules, while SCK CEN provides Tb-161, infrastructure, and expertise in preclinical testing.
-
3 weeks ago | 
auntminnieeurope.com | Will Morton |Philip Ward |Edna Astbury-Ward
The European Association of Nuclear Medicine (EANM) has added 50 spots in its initiative to support the young generation of nuclear medicine professionals, the Next-Gen Program. Accepted applicants (under the age of 39) will receive free registration, free accommodation, and specific opportunities to network at the association’s 2025 annual meeting to be held from 4 to 8 October in Barcelona, Spain. Last year, EANM received 600 applications for 100 spots, and is offering 150 spots this year.
-
3 weeks ago | 
auntminnieeurope.com | Philip Ward |Edna Astbury-Ward |Will Morton |Erik L. Ridley
Radiotherapy developer Actinium Pharmaceuticals is launching ATNM-400, a novel, non-prostate-specific membrane antigen (PSMA) targeting radiotherapy for prostate cancer that uses the actinium-225 (Ac-225) radioisotope. Initial preclinical data from a study on ATNM-400's performance will be presented at the American Association for Cancer Research (AACR) annual meeting being held between 25 and 30 April 25 in Chicago.
-
3 weeks ago | 
auntminnieeurope.com | Erik L. Ridley |Amerigo Allegretto |Philip Ward |Edna Astbury-Ward
AI could help sonographers find fetal abnormalities faster without sacrificing diagnostic quality, according to research published on 27 March in the New England Journal of Medicine. A team led by Thomas Day, PhD, from King’s College London in the U.K., found that AI sped up scan times by more than eight minutes and achieved high marks in detecting fetal malformations.
-
3 weeks ago | 
auntminnieeurope.com | Will Morton |Philip Ward |Edna Astbury-Ward
Researchers have proposed a fresh approach derived from brain PET imaging for diagnosing and staging Alzheimer’s disease. The method is based on the amount of the brain “filled” with three hallmark pathologic abnormalities associated with the disease – amyloid, tau, and neurodegeneration – and could become a valuable tool for clinicians, noted first author Elena Doering, from the Department of Nuclear Medicine at the University of Cologne, and colleagues.
-
4 weeks ago | 
auntminnieeurope.com | Will Morton |Philip Ward |Edna Astbury-Ward
GE HealthCare and private hospital group Swiss Medical Network have agreed to establish a molecular imaging and theranostics center of excellence at Clinique de Genolier, located 25 km from Geneva and 35 km from Lausanne. The vendor and network have signed an agreement under which GE will provide equipment, access to proprietary tools and technologies, and support for research projects at Clinique de Genolier.
-
1 month ago | 
auntminnieeurope.com | Philip Ward |Edna Astbury-Ward |Will Morton |Erik L. Ridley
Eckert & Ziegler and AtomVie Global Radiopharma have entered a worldwide supply agreement in which Eckert & Ziegler will provide non-carrier-added lutetium-177 (Lu-177) chloride (Theralugand) to support AtomVie's manufacturing capabilities. The collaboration covers both early and late-stage development and extends to programs around the world. Through this partnership, AtomVie secures access to Theralugand, which will spur more development of Lu-177-based radiopharmaceuticals in their facility.
-
1 month ago | 
auntminnieeurope.com | Edna Astbury-Ward |Philip Ward |Amerigo Allegretto
Muscle tears in older patients have increased in recent decades, according to a statement issued by the Spanish Society of Medical Radiology (SERAM). Dr. Javier Fernández Jara, a musculoskeletal radiologist at Sanitas La Zarzuela University Hospital, noted that several factors are contributing to this trend. These include greater longevity and active aging, older adults being more physically active today, an increase in diagnoses, and advances in imaging technologies in detecting muscle tears.
